Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin plumping refers to a complex physiological state of the skin characterized by high hydration levels, significant dermal volume, and structural integrity, rather than representing a single discrete molecular target. The primary biological driver of this effect is Hyaluronic acid (HA), a glycosaminoglycan that acts as a potent humectant by binding up to 1,000 times its weight in water within the extracellular matrix (ECM) [1, 13, 14]. This hygroscopic action provides the turgor and volume necessary for a smooth, firm appearance, while structural proteins like Collagen and Elastin provide the mechanical scaffolding that prevents sagging [4, 18]. At the molecular level, the interaction between HA and its principal cell-surface receptor, CD44, is essential for regulating HA homeostasis, keratinocyte proliferation, and the maintenance of the epidermal barrier [6, 9]. Therapeutic strategies targeting this state include the administration of exogenous HA through fillers or topical serums, and the use of retinoids or bioactive peptides to stimulate the endogenous synthesis of structural ECM components [11, 15, 16]. Clinically, the loss of skin plumpness is a hallmark of both intrinsic and extrinsic aging, often characterized by increased matrix metalloproteinase activity and diminished glycosaminoglycan production [2, 11, 13].
Enhancement of dermal and epidermal volume through hygroscopic water retention and the stimulation of fibroblast-mediated synthesis of structural proteins (collagen, elastin) and glycosaminoglycans.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin plumping.